Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Current Assets (2016 - 2025)

Historic Current Assets for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $10.7 million.

  • Nephros' Current Assets rose 4554.11% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 4554.11%. This contributed to the annual value of $8.3 million for FY2024, which is 127.31% down from last year.
  • According to the latest figures from Q3 2025, Nephros' Current Assets is $10.7 million, which was up 4554.11% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Nephros' Current Assets registered a high of $14.8 million during Q2 2021, and its lowest value of $7.4 million during Q3 2024.
  • For the 5-year period, Nephros' Current Assets averaged around $10.1 million, with its median value being $9.0 million (2025).
  • Its Current Assets has fluctuated over the past 5 years, first plummeted by 3940.88% in 2022, then skyrocketed by 4554.11% in 2025.
  • Over the past 5 years, Nephros' Current Assets (Quarter) stood at $13.6 million in 2021, then tumbled by 39.41% to $8.3 million in 2022, then grew by 1.74% to $8.4 million in 2023, then dropped by 1.27% to $8.3 million in 2024, then increased by 29.02% to $10.7 million in 2025.
  • Its Current Assets was $10.7 million in Q3 2025, compared to $9.6 million in Q2 2025 and $9.0 million in Q1 2025.